Bath & Body Works (NYSE:BBWI) Issues Q2 2026 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its second quarter 2026 earnings guidance on Wednesday. The company provided EPS guidance of 0.300-0.300 for the period, compared to the consensus EPS estimate of 0.200. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Bath & Body Works also updated its FY 2026 guidance to 2.400-2.650 EPS.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. UBS Group reduced their target price on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. Telsey Advisory Group raised their target price on shares of Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a report on Thursday, March 5th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a report on Wednesday. Citigroup cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and raised their price objective for the stock from $21.00 to $25.00 in a report on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Tuesday, March 3rd. Three investment analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $21.21.

Bath & Body Works Trading Up 10.3%

BBWI stock opened at $19.56 on Thursday. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $33.96. The company’s 50 day moving average is $18.65 and its two-hundred day moving average is $20.24. The stock has a market cap of $3.94 billion, a P/E ratio of 6.21, a PEG ratio of 1.76 and a beta of 1.43.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The company had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. During the same quarter last year, the company earned $0.49 earnings per share. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities research analysts predict that Bath & Body Works will post 2.61 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a yield of 4.1%. Bath & Body Works’s dividend payout ratio (DPR) is presently 25.40%.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Bath & Body Works topped Q1 estimates with adjusted EPS of $0.32 versus $0.29 expected and revenue of $1.38 billion versus $1.36 billion forecast, helping drive a sharp rally in the stock. Bath & Body Works beats quarterly estimates on strong demand for ‘affordable luxury’
• Positive Sentiment: Management said turnaround momentum is building and reaffirmed full-year 2026 guidance, which suggests the business is performing better than feared despite lower sales year over year. Bath & Body Works Reports First Quarter Results Exceeding Guidance and Progress Against the Consumer First Formula
• Positive Sentiment: The company also guided Q2 adjusted EPS to $0.30, above the $0.20 consensus, reinforcing confidence in near-term profitability. Bath & Body Works, Inc. (NYSE:BBWI) Receives Consensus Recommendation of “Hold” from Brokerages
• Neutral Sentiment: Analyst sentiment remains cautious overall, with brokerages maintaining a consensus “Hold” rating on the stock.
• Negative Sentiment: Revenue still fell 3.2% year over year in the quarter, showing the turnaround is not complete and sales pressure remains a headwind for the stock.
• Negative Sentiment: Bath & Body Works also disclosed that CFO Eva Boratto will step down in June, adding some leadership uncertainty even as the company searches for an interim replacement.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds have recently modified their holdings of the business. Parallel Advisors LLC grew its position in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the last quarter. Meeder Asset Management Inc. grew its position in shares of Bath & Body Works by 28.5% during the fourth quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after acquiring an additional 637 shares during the last quarter. State of Wyoming grew its position in shares of Bath & Body Works by 6.2% during the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after acquiring an additional 661 shares during the last quarter. Vident Advisory LLC grew its position in shares of Bath & Body Works by 2.8% during the second quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after acquiring an additional 692 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its position in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.